A comparison of efficacy between combination use of methylergonovine intravenous slowly push plus oxytocin continuous infusion and carbetocin intravenous slowly push for prevent postpartum hemorrhage in cesarean sectio
Phase 4
- Conditions
- postpartum hemorrhage ,cesarean sectioncarbetocin ,oxytocin ,methylergonovine ,prevention ,
- Registration Number
- TCTR20200401001
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
singleton pregnancy gestational age between 34-42 weeks
Exclusion Criteria
pregnancy with
- eclampsia or preeclampsia
- hypertension
- coagulation disorder
- anemia
- polycythemia
- blood transfusion
- ischemic heart disease
- cerebrovascular disease
- peripheral vascular disease
- asthma
- placenta previa
- placental abruption
- allergy to carbetocin , oxytocin or methylergonovine
- cannot speak thai language
- fetal distress
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduced blood loss after cesareansection 4 hours two sample t test
- Secondary Outcome Measures
Name Time Method side effect from drug intra-operative and post-operative Chi-square test